Published in
Oxford University Press, Journal of Antimicrobial Chemotherapy, 2(70), p. 498-504, 2014
DOI: 10.1093/jac/dku421
Links
Tools
Activity of oritavancin against Gram-positive clinical isolates responsible for documented skin and soft-tissue infections in European and US hospitals (2010-13)
Journal article published in 2014 by
R. E. Mendes 
,
D. J. Farrell,
H. S. Sader,
R. K. Flamm,
R. N. Jones
,
D. J. Farrell,
H. S. Sader,
R. K. Flamm,
R. N. Jones
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 